Centogene Launches 2-Year Global ROPAD Study to Assess the Genetics of Parkinson’s Disease

Centogene Launches 2-Year Global ROPAD Study to Assess the Genetics of Parkinson’s Disease
A two-year, global, observational study that will assess the contribution of genetic factors in the development of Parkinson’s disease has been launched by Centogene, in collaboration with the University of Lübeck. The new study (NCT03866603), which is called “Rostock International Parkinson’s Disease Study” or ROPAD, seeks to enroll around 10,000 participants worldwide to get a representative snapshot of the genetic ... read more
Source: Parkinson’s News TodayPublished on 2019-05-14By Joana Carvalho